Biblio
“Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.”, Am J Hum Genet, vol. 73, no. 5, pp. 1041-51, 2003.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.
, “Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”, Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.
, “Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.”, Neurogenetics, vol. 9, no. 1, pp. 51-60, 2008.
, “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
, “Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.”, Genome Med, vol. 10, no. 1, p. 43, 2018.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “The ubiquilin 1 gene and Alzheimer's disease.”, N Engl J Med, vol. 352, no. 26, pp. 2752-3; author reply 2752-3, 2005.
, “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
, “Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.”, Proc Natl Acad Sci U S A, vol. 98, no. 11, pp. 6354-9, 2001.
, “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
, “Genome-wide association analysis of age-at-onset in Alzheimer's disease.”, Mol Psychiatry, vol. 17, no. 12, pp. 1340-6, 2012.
, “Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.”, Alzheimers Dement, vol. 12, no. 1, pp. 2-10, 2016.
, “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “A survey of genetic human cortical gene expression.”, Nat Genet, vol. 39, no. 12, pp. 1494-9, 2007.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
,